Los Angeles Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.64M	Buy	154,422 +89,919	+139%	+$2.29M	0.01%	387
2025 Q4	$1.61M	Buy	64,503 +1,478	+2%	+$37.8K	0.01%	497
2025 Q3	$1.19M	Buy	63,025 +32,162	+104%	+$507K	﹤0.01%	659
2025 Q2	$433K	Hold	30,863	–	–	﹤0.01%	910
2025 Q1	$483K	Buy	30,863 +70	+0.2%	+$986	﹤0.01%	753
2024 Q4	$429K	Sell	30,793 -94,310	-75%	-$1.03M	﹤0.01%	847
2024 Q3	$1.16M	Sell	125,103 -10,845	-8%	-$107K	﹤0.01%	604
2024 Q2	$1.26M	Sell	135,948 -12,485	-8%	-$113K	﹤0.01%	572
2024 Q1	$1.47M	Sell	148,433 -46,028	-24%	-$344K	0.01%	573
2023 Q4	$628K	Buy	+194,461	New	+$529K	﹤0.01%	814
2022 Q2	–	Sell	-26,257	Closed	-$506K	–	1323
2022 Q1	$506K	Sell	26,257 -1,720	-6%	-$29.1K	﹤0.01%	1019
2021 Q4	$580K	Buy	27,977 +7	+0%	+$139	﹤0.01%	936
2021 Q3	$668K	Buy	27,970 +1,280	+5%	+$29.2K	﹤0.01%	925
2021 Q2	$728K	Buy	+26,690	New	+$752K	﹤0.01%	1000